Patent · US Expired

Process and reagent for the specific determination of HDL cholesterol in serum or plasma

US4851335A · kind A · utility

18Cited by
6References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 16, 1986
Grant dateJul 25, 1989
Priority date
Expiry dateSep 16, 2006

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/92
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention provides a process for the specific determination of HDL cholesterol in serum or plasma by incubation with a cholesterol detection system, containing cholesterol oxidase and cholesterol esterase in a buffered aqueous medium, and measurement of a product of the cholesterol oxidase reaction or of the oxygen consumption, wherein a sample to be tested is incubated in the presence of a salt of a bile acid or of a bile acid derivative or of dioctylsulphosuccinate, a first measurement is then carried out, subsequently a non-ionic, polyethylene oxide group-containing detergent or a secondary alkane sulphonate is added, again incubated and a second measurement is carried out, the amount of HDL cholesterol being determined from the difference between the first and second measurement. The present invention also provides a reagent for the specific determination of HDL cholesterol in serum or plasma containing cholesterol oxidase, buffer and cholesterol esterase, wherein, referred to the final solution, it contains PA0 0.1 to 10 U/ml. cholesterol esterase PA0 0.05 to 10 U/ml. cholesterol oxidase PA0 20 to 500 mmole/liter buffer substance (pH 6.0 to 8.0) PA0 0.2 to 20 mmole…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.